Growth Metrics

Mimedx Group (MDXG) Income from Continuing Operations: 2011-2025

Historic Income from Continuing Operations for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $16.7 million.

  • Mimedx Group's Income from Continuing Operations rose 112.59% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.8 million, marking a year-over-year decrease of 52.44%. This contributed to the annual value of $42.0 million for FY2024, which is 37.72% down from last year.
  • Per Mimedx Group's latest filing, its Income from Continuing Operations stood at $16.7 million for Q3 2025, which was up 74.13% from $9.6 million recorded in Q2 2025.
  • Mimedx Group's Income from Continuing Operations' 5-year high stood at $51.3 million during Q4 2023, with a 5-year trough of -$10.9 million in Q2 2022.
  • Over the past 3 years, Mimedx Group's median Income from Continuing Operations value was $9.1 million (recorded in 2024), while the average stood at $13.0 million.
  • The largest annual percentage gain for Mimedx Group's Income from Continuing Operations in the last 5 years was 4,839.70% (2022), contrasted with its biggest fall of 510.91% (2022).
  • Mimedx Group's Income from Continuing Operations (Quarterly) stood at $199,000 in 2021, then soared by 4,839.70% to $9.8 million in 2022, then skyrocketed by 421.75% to $51.3 million in 2023, then tumbled by 85.50% to $7.4 million in 2024, then spiked by 112.59% to $16.7 million in 2025.
  • Its Income from Continuing Operations was $16.7 million in Q3 2025, compared to $9.6 million in Q2 2025 and $7.0 million in Q1 2025.